Patent Assignment
Reel/Frame 058264/0826
Corrective Assignment to Correct the Assignee from Aardvark Therapeutics Inc to Aardvark Therapeutics, Inc & Update Address of Assignee Previously Recorded at Reel: 055631 Frame: 0042. Assignor(S) Hereby Confirms the Assignment.
Recorded: 2021-11-29
Pages: 8
Assignee
AARDVARK THERAPEUTICS, INC.
4747 EXECUTIVE DRIVE, SUITE 1020, SAN DIEGO, CALIFORNIA, 92121
Covered Property
(1)
Oral Delayed Burst Formulation of Low-Dose Naltrexone or Naloxone and Methods for treating Fibromyalgia and Long COVID
Application:
63/154,795 →
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 18, 2021
From: ZHENG, ZHENHUAN; LEE, TIEN-LI
To: AARDVARK THERAPEUTICS INC
Reel/Frame 055631/0042 →
Assignment of Assignor's Interest
Nov 29, 2021
From: AARDVARK THERAPEUTICS, INC.
To: SORRENTO THERAPEUTICS, INC.
Reel/Frame 058230/0844 →
Confirmatory Assignment
Nov 29, 2021
From: AARDVARK THERAPEUTICS, INC.
To: SORRENTO THERAPEUTICS, INC.
Reel/Frame 058732/0085 →
Confirmatory Assignment
Nov 29, 2021
From: ZHENG, ZHENHUAN; LEE, TIEN-LI
To: AARDVARK THERAPEUTICS, INC.
Reel/Frame 058957/0358 →
Assignment of Assignor's Interest
Jun 29, 2022
From: SORRENTO THERAPEUTICS, INC.
To: SCILEX HOLDING COMPANY
Reel/Frame 060543/0076 →